Clinical Trials
16 trialsNCT07008508 2025-06-06
BRAVE-Cyclin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Active not recruiting
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT03381963 2020-04-09
HEMOBREAST
University Hospital, Geneva
Completed
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT03889171 2019-03-28
PSICOM
University Hospital, Montpellier
Completed
NCT03618810 2018-12-27
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
Zhejiang Cancer Hospital
Unknown
NCT02178475 2018-07-23
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
Amgen
Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT01813721 2017-03-15
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Amgen
Completed
NCT00580021 2016-01-28
Clinical Outcomes in Hereditary Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT00676065 2014-11-19
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Center for Epidemiology and Health Research, Germany
Completed
NCT00776958 2014-07-31
Lynne Cohen Consortium Project: Multi-Center Database/Registry
M.D. Anderson Cancer Center
Completed
NCT00509509 2012-05-24
High Risk Breast Cancer Screening Program
Organisation for Oncology and Translational Research
Unknown